Navigation Links
Study Links Cancerous Tumors With Depression
Date:5/20/2009

Research with rats finds biological tie between growths and mood changes

WEDNESDAY, May 20 (HealthDay News) -- Doctors have long known that people with cancer often suffer from depression.

A new study in rats has found that the cause of the depression may be the properties of the tumor itself, rather than emotional distress over the diagnosis or side effects from chemotherapy.

The study is the first to identify a biological link between tumors and negative mood changes, according to the researchers, who published their study in the May 18 issue of the Proceedings of the National Academy of Sciences.

About 15 percent to 20 percent of patients diagnosed with cancer experience depression, according to the U.S. National Cancer Institute.

Researchers put about 100 rats through a series of exercises commonly used by researchers testing antidepressants in animal models. Some of the rats had cancerous tumors.

The investigators found that the rats with tumors were less motivated to escape when submitted to a swimming test, a condition that is similar to depression in humans. The rats with tumors also were less eager to drink sugar water, a substance that healthy rats usually find irresistible.

"In this case, examining behavioral responses to tumors in non-human animals is particularly useful, because the rats have no awareness of the disease, and thus their behavioral changes were likely the result of purely biological factors," said senior study author Brian Prendergast, associate professor of psychology at the University of Chicago.

The team determined that substances associated with depression are produced in increased quantities by tumors and are transmitted to the brain.

Additionally, pathways that normally moderate the impact of depression-causing substances are disrupted when a tumor develops.

Tumors induce changes in gene expression in the hippocampus, the portion of the brain that regulates emotion.

Rats with tumors had increased levels of cytokines in their blood and in the hippocampus when compared with healthy rats. Previous research has linked high levels of cytokines, which are produced by the immune system, to depression.

The research team also found that stress hormone production was altered in rats with tumors.

The rats with tumors had dampened production of the stress hormone corticosterone, which helps regulate the impact of cytokines. Reducing the production of corticosterone may increase the impact of cytokines.

"Our research shows that two types of tumor-induced molecules, one secreted by the immune system and another by the stress axis, may be responsible," said Leah Pyter, a postdoctoral fellow at the University of Chicago and lead study author. "Both of these substances have been implicated in depression, but neither has been examined over time frames and magnitudes that are characteristic of chronic diseases such as cancer."

More information

The U.S. National Cancer Institute has more on cancer and depression.



-- Jennifer Thomas



SOURCE: University of Chicago, news release, May 18, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Study Reveals Wide Variations in Depression Diagnoses among Ethnic Groups
2. HIMSS Analytics and NetMotion Wireless Release Study Findings on Key Challenges for Wireless Healthcare Deployments
3. Stem Cell Study Offers Hope for Targeting Tumors
4. Study Reiterates Eye Risks Linked to Flomax
5. Study Shows NeuroStar TMS Therapy(R) Improved Key Elements of Cognition in Patients with Major Depressive Disorder
6. BioHorizons Reports on Comparative 3-Year Dental Implant Study Showing Significant Crestal Bone and Soft Tissue Retention Using Laser-Lok(R) Microchannels
7. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
8. SYNTAX Substudy Shows Positive Outcomes for Left Main Patients Treated With TAXUS(R) Express2(R) Stent System
9. MS Patients More Compliant with Medications When Managed by Specialty Pharmacy, According to HealthCore Study Presented at ISPOR
10. Deloitte Comparative Effectiveness Study Evaluates Potential Savings Opportunities for U.S. Health Care System
11. Workplace E-Mail Intervention Program Helps People Sit Less and Eat Better, Kaiser Permanente Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Links Cancerous Tumors With Depression
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop Inc. , ... . This new addition to the Mirroring360 product family combines device screen mirroring ... Mirroring360 Pro enables educators, business professionals and individuals to stream or mirror app ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... CFOs and HR decision-makers are preparing for how his administration could impact the ... provide insight into what changes are most likely to make it through Congress. ...
(Date:4/25/2017)... NV (PRWEB) , ... April 25, 2017 , ... ... now choose a modern procedure that achieves results in a fraction of the ... in Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary treatment ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... Hollywood, Fl (PRWEB) , ... April 25, 2017 , ... ... than Memorial Regional Hospital, according to a special report in the May issue of ... Hospital its highest quality ranking for results achieved during and after coronary bypass ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 The Global Effective ... to 2022 report has covered and analysed the potential of ... on market size, shares and growth factors. The report identifies ... and opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major Company ...
(Date:4/19/2017)... THOUSAND OAKS, Calif. , April 19, 2017 ... premium industrial buildings it is developing at Conejo ... California , to Atara Biotherapeutics, Inc. ... patients with severe and life-threatening diseases that have ... focus on allogeneic T-cell therapies for cancer, autoimmune ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., developer ... series to be presented at the 2017 National Kidney ... today and continues through April 22. Physicians will present ... used to assess risk for acute kidney injury (AKI) ... failure (ADHF). Elevated levels of TIMP-2 ...
Breaking Medicine Technology: